Researchers in cancer biology and oncology research

James G. Herman

James G. Herman is an American physician-scientist in cancer epigenetics who developed methylation-specific PCR, the method that made promoter DNA methylation detectable in routine clinical samples.

James J. Hsieh

James J. Hsieh, also known as James Hsieh, is a physician-scientist who cloned the protease Taspase1 and studies clear cell renal cell carcinoma at Washington University.

James K. McDougall was a viral oncology researcher and epidemiologist who, working at Fred Hutchinson Cancer Research Center in Seattle, made critical discoveries linking human papillomaviruses to cervical and other cancers.

James L. Abbruzzese

James L. Abbruzzese is an American medical oncologist known for pancreatic cancer treatment, who chaired gastrointestinal oncology at MD Anderson for 17 years before joining Duke.

James N. Kochenderfer

James N. Kochenderfer is an American physician-scientist at the National Cancer Institute in Bethesda, Maryland, whose laboratory develops CAR T-cell immunotherapies for lymphoma, leukemia, and multiple myeloma.

James P. Allison

James P. Allison, American immunologist born in Alice, Texas, discovered CTLA-4 is a T-cell brake; blocking it produced ipilimumab, the first checkpoint inhibitor, and the 2018 Nobel Prize shared with Tasuku Honjo.

James R. Downing

James R. Downing is a physician-scientist in pediatric cancer genomics who spent his career at St. Jude Children's Research Hospital, serving as president and CEO from 2014, and co-founded the Pediatric Cancer Genome Project.

Jamie L. Renbarger

Jamie L. Renbarger is an American pediatric hematology-oncology physician-scientist who spent 21 years at Indiana University studying chemotherapy toxicities in children, winning a PECASE award in 2011.

Jan B. Vermorken

Jan B. Vermorken is a Dutch medical oncologist who led medical oncology at the University of Antwerp and Antwerp University Hospital, known for the EXTREME and TAX 323 trials.

Jan Korbel

Jan O. Korbel is a geneticist and group leader at EMBL Heidelberg, where he has led research on genomic structural variation and cancer since 2008 and co-discovered chromothripsis.

Jane C. Weeks

Jane C. Weeks, also known as Jane Weeks, was an American oncologist at Dana-Farber Cancer Institute who pioneered cancer outcomes research before her death in 2013.

Janean Holden

Janean Holden is an American nurse scientist at the University of Michigan who studies how the brain modulates pain and, in 1999, became the first nurse scientist to receive a Presidential Early Career Award.

Janet D. Rowley

Janet D. Rowley (1925–2013) was an American hematologist at the University of Chicago who founded cancer cytogenetics, showing in 1973 that the Philadelphia chromosome is a translocation.

Janet R. Daling

Janet R. Daling (1934–2022) was an American cancer epidemiologist at the Fred Hutchinson Cancer Center in Seattle, known for landmark studies linking HPV to anal cancer and IUD use to infertility.

Janis L. Abkowitz

Janis L. Abkowitz is an American hematologist at the University of Washington known for research on marrow-failure syndromes and elected to the National Academy of Medicine in 2013.

Jason R. Westin

Jason R. Westin, also known as Jason Westin, is an American oncologist and lymphoma researcher at MD Anderson Cancer Center, known for leading the ZUMA-7 CAR T-cell therapy trial.

Javier Cortés

Javier Cortés is a Spanish breast medical oncologist who led the phase 3 trials CLEOPATRA, KEYNOTE-355, DESTINY-Breast03, and ASCENT, and directs the International Breast Cancer Center in Barcelona.

Oct 10, 2026

Jay Bradner

James "Jay" E. Bradner is an American physician-scientist who created the chemical probe JQ1, shared it freely to spur open-source drug discovery, and joined Amgen in 2023.

Jayanta Debnath

Jayanta Debnath is an American cancer biologist and pathologist who chairs pathology at UCSF, where his laboratory studies autophagy as a survival mechanism in cancer.

Jean Bourhis

Jean Bourhis is a French radiation oncologist, professor and chair of radiation oncology at Lausanne University Hospital since 2012, known for the MACH-NC and MARCH meta-analyses.

Jean E. Johnson

Jean E. Johnson, full name Jean Elaine Irwin Johnson (1925–2022), was an American nurse scientist at the University of Rochester known for self-regulation theory in patient education.

Jean Klášterský

Jean Klášterský (Jean Klastersky), born 1940 in Prague, is a Belgian medical oncologist who led the Institut Jules Bordet in Brussels and created the MASCC risk index.

Jean Paul Thiery

Jean Paul Thiery is a French cell and cancer biologist whose work on epithelial-mesenchymal transition established it as a central mechanism of carcinoma progression and metastasis.

Jean‐Charles Soria

Jean-Charles Soria is a French medical oncologist known for early-phase cancer drug development and for leading the FLAURA trials of osimertinib in EGFR-mutated non-small-cell lung cancer.

Jean‐Marie Andrieu

Jean-Marie Andrieu was a French hematologist, oncologist, and professor of medicine at Université Paris Descartes who led Hôpital Européen Georges Pompidou's oncology department and developed therapeutic dendritic-cell vaccines against HIV.

Jean‐Yves Blay

Jean-Yves Blay is a French medical oncologist, Directeur général of the Centre Léon Bérard in Lyon, professor at Université Claude Bernard Lyon 1, and president of Unicancer.

Jean‐Yves Douillard

Jean-Yves Douillard is a French medical oncologist who worked on lung and gastrointestinal cancers, led the PRIME trial of panitumumab, and became ESMO's first Chief Medical Officer in 2016.

Jeanmarie Houghton

Jeanmarie Houghton is an American physician-scientist and Professor of Medicine at UMass Chan Medical School, best known for her 2004 Science paper reporting gastric cancer originating from bone marrow-derived cells.

Jeanne S. Mandelblatt

Jeanne S. Mandelblatt is an American geriatrician and professor of oncology at Georgetown University, founder of its Institute for Cancer and Aging Research and leader of CISNET breast cancer modeling.